Transcript Slide 1 - Oncoletter
Prevention of Early Menopause Study
(POEMS)-S0230
Phase III trial of LHRH analog during chemotherapy to reduce ovarian failure in early stage, hormone receptor negative breast cancer: an international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance)
Presented By Halle Moore at 2014 ASCO Annual Meeting
Background
Presented By Halle Moore at 2014 ASCO Annual Meeting
Ovarian Protection with LHRH analog
Presented By Halle Moore at 2014 ASCO Annual Meeting
POEMS/S0230 Schema
Presented By Halle Moore at 2014 ASCO Annual Meeting
POEMS Objectives and Endpoints
Presented By Halle Moore at 2014 ASCO Annual Meeting
Goserelin Administration
Presented By Halle Moore at 2014 ASCO Annual Meeting
Patient Eligibility
Presented By Halle Moore at 2014 ASCO Annual Meeting
Statistical Considerations
Presented By Halle Moore at 2014 ASCO Annual Meeting
POEMS Consort Diagram
Presented By Halle Moore at 2014 ASCO Annual Meeting
Patients
Presented By Halle Moore at 2014 ASCO Annual Meeting
Endocrine Toxicity
Presented By Halle Moore at 2014 ASCO Annual Meeting
POEMS Ovarian Failure
Presented By Halle Moore at 2014 ASCO Annual Meeting
POEMS Secondary Ovarian Outcomes
Presented By Halle Moore at 2014 ASCO Annual Meeting
POEMS Pregnancy
Presented By Halle Moore at 2014 ASCO Annual Meeting
POEMS Disease Free Survival
Presented By Halle Moore at 2014 ASCO Annual Meeting
POEMS Overall Survival
Presented By Halle Moore at 2014 ASCO Annual Meeting
POEMS
Presented By Halle Moore at 2014 ASCO Annual Meeting
Conclusions
Presented By Halle Moore at 2014 ASCO Annual Meeting
Acknowledgements
Presented By Halle Moore at 2014 ASCO Annual Meeting